Timing your meals could be key to blood sugar control, new study suggests

NCT ID NCT06118931

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study looks at whether the timing of a 9-hour eating window (early, mid, or late in the day) affects blood sugar control in people with obesity who have or are at risk for type 2 diabetes. Over 7 days, 120 participants will follow one of three time-restricted eating schedules while wearing a continuous glucose monitor. The goal is to see if starting the eating window earlier or later makes a difference in average blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

time-restricted eating (intermittent fasting with a 9-hour eating window)

What this could lead to

If successful, this could show that simply adjusting when you eat (not what you eat) helps control blood sugar, offering a practical lifestyle tool for managing or preventing type 2 diabetes.

What could go wrong

This is a short, early-stage study (7 days) with only 120 participants, so results may not apply to longer-term use or to everyone. It also does not restrict food quality or amount, which could limit blood sugar benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperglycemia Intermittent Fasting Obesity obesity disorder prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Remote Ontario-wide

    RECRUITING

    Toronto, Ontario, Canada

    Contact

    Contact